Showing results (641-650 of 664) with videos related to

Sort By:
Pageof 67
BMJ Open Diabetes Research & Care|February 27, 2026
Comparative safety of sulfonylurea therapies on cardiovascular and severe hypoglycemia outcomes among adults with type 2 diabetes and moderate cardiovascular risk: a target trial emulationStacey Sklepinski, Alexandria A Ratzki-Leewing, Jeph Herrin, et al.
Circulation. Cardiovascular Quality and Outcomes|December 25, 2009
An administrative claims measure suitable for profiling hospital performance on the basis of 30-day all-cause readmission rates among patients with heart failurePatricia S Keenan, Sharon-Lise T Normand, Zhenqiu Lin, et al.
Journal of the American College of Cardiology|January 20, 2010
National efforts to improve door-to-balloon time results from the Door-to-Balloon AllianceElizabeth H Bradley, Brahmajee K Nallamothu, Jeph Herrin, et al.
BMJ (Clinical Research Ed.)|July 23, 2024
Learning implementation of a guideline based decision support system to improve hypertension treatment in primary care in China: pragmatic cluster randomised controlled trialJiali Song, Xiuling Wang, Bin Wang, et al.
Lancet (London, England)|October 19, 2006
Effect of payments for health care on poverty estimates in 11 countries in Asia: an analysis of household survey dataEddy van Doorslaer, Owen O'Donnell, Ravi P Rannan-Eliya, et al.
Human Vaccines & Immunotherapeutics|December 9, 2014
Comparison of adaptive and innate immune responses induced by licensed vaccines for Human PapillomavirusDouglas M Herrin, Emily E Coates, Pamela J Costner, et al.
European Urology|December 4, 2021
A Clinical Decision Aid to Support Personalized Treatment Selection for Patients with Clinical T1 Renal Masses: Results from a Multi-institutional Competing-risks AnalysisSarah P Psutka, Roman Gulati, Michael A S Jewett, et al.
Scientific Reports|May 13, 2022
Sotatercept analog suppresses inflammation to reverse experimental pulmonary arterial hypertensionSachindra R Joshi, Jun Liu, Troy Bloom, et al.
Journal of Medicinal Chemistry|January 19, 1996
A novel, picomolar inhibitor of human immunodeficiency virus type 1 proteaseH L Sham, C Zhao, K D Stewart, et al.
The American Journal of Medicine|May 12, 2024
The PAX LC Trial: A Decentralized, Phase 2, Randomized, Double-Blind Study of Nirmatrelvir/Ritonavir Compared with Placebo/Ritonavir for Long COVIDHarlan M Krumholz, Mitsuaki Sawano, Bornali Bhattacharjee, et al.
Pageof 67